• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Rate of change of Antimüllerian hormone (AMH) is an independent predictor of time to menopause in late reproductive age women

bys25qthea
November 3, 2012
in Obstetrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Key study points:

 1. In women aged 35-48 years old, rate of AMH change was independently associated with risk of menopause.

 2. Including rate of AMH change with baseline AMH level and age increased the precision of estimates of time to menopause.

Primer: Menopause is defined as the cessation of menstruation for 12 months, which represents complete or near complete ovarian follicular depletion. Perimenopause, or the menopausal transition, represents the shift from regular ovulatory cycles to permanent infertility. In the United States, the median age of menopause is 51.4 years and of perimenopause is about 46 (1).

Accurately diagnosing the menopausal transition is clinically necessary when women present for infertility evaluation (3) or when they present with symptoms of peri-menopause (e.g. amenorrhea, vasomotor symptoms) that overlap with other conditions such as hyperthyroidism, pregnancy, carcinoid and hyperprolactinemia. In either setting, the Staging of Reproductive Aging Workshop (STRAW) staging criteria can be used as a tool to assess ovarian reserve in infertility patients or to approximate time to menopause, though the criteria (antral follicle count, follicle-stimulating hormone (FSH), anti-müllerian hormone (AMH) and inhibin B levels) have not been validated for use in the evaluation of menopausal status (2). In a woman undergoing the menopausal transition, FSH is high due to disinhibition of the anterior pituitary while AMH, inhibin B and AFC are low because the ovaries produce less hormones (low AMH, inhibin B and estrogen) and less follicles are recruited in a hypoestrogenic setting.

In the ART population, fertility specialists rely on FSH and AMH as serum markers of ovarian reserve. Historically, measuring FSH and estrogen levels on Day 3 and 10 after a clomid challenge test has been standard practice for approximating ovarian reserve (3). However, in 2001 research showed that AMH may be a more reliable marker (4). AMH is further favorable because it is not cycle-dependent such that it can be measured at any time in a woman’s cycle. Further, AMH measurement does not require an antecedent clomid challenge, as does measurement of FSH (5).

RELATED REPORTS

Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy

#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk

St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes

The present work is the first to assess the rate of AMH change as a predictor of ovarian follicular atresia.

Background reading: 

  1. Up-to-Date: Diagnosis of Menopause
  2. Executive Summary: Staging Reproductive Aging
  3. Up-to-Date: Female Infertility
  4. AMH: a putative marker of ovarian aging
  5. AMH better predictive marker than FSH

This [prospective cohort] study evaluated 293 premenopausal women in the Penn Ovarian Aging Study who had both a detectable baseline AMH level (at least 0.20ng/mL) and at least one additional AMH measure 1 or more years later. The cohort was randomly identified by telephone and stratified to obtain equal numbers of black and white women.

Overall, results showed that including rate of AMH change along with baseline AMH level and age increased the precision of estimates of time to menopause. The rate of AMH change was associated with time to menopause in late reproductive age women (35-48 years old) such that women with similar baseline AMH levels experienced time to menopause that differed by about 2 years between those with a slow versus fast rate of AMH change. Interestingly, women in the 35-39 age group with faster decrease in AMH experienced a dramatically increased risk of menopause (Hazard ratio: 6.97, 95% CI 3.81-12.72) while women in the 40-44 and 45-48 age groups experienced a less dramatic but still significant associations.

In sum: The results of the present work suggest that the rate of AMH change may be a more direct surrogate than age or single AMH measurement in predicting time to menopause.

Click to read this article in the current issue of Fertility and Sterility

By [LH]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Terminal cancer patients hold misconceptions of the role of chemotherapy

Next Post

Nutrient-enriched formula linked to increased head circumference and lower fat mass in a subset of preterm infants

RelatedReports

Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Emergency

Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy

July 15, 2025
#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
StudyGraphics

#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk

July 15, 2025
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Emergency

St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes

July 14, 2025
Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis
All Specialties

Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes

July 14, 2025
Next Post

Nutrient-enriched formula linked to increased head circumference and lower fat mass in a subset of preterm infants

Paternal factors found to significantly influence certain adolescent sexual behaviours

Classics Series, Landmark Trials in Medicine

The CURE trial: Clopidogrel in ACS without ST-elevation [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy
  • #VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.